Intermediate for Efinaconazole. Efinaconazole (trade names: Jublia and Clenafin) is a 14α-demethylase inhibitor for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole has been approved by the U.S Food and Drug Administration on June 6, 2014.


Product Name:                  (2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol

Synonyms:                         N/A

CAS Number:                     133775-25-4

Molecular Weight:            269.2504

Molecular Formula:          C12H13F2N3O2

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Fc1ccc(c(c1)F)[C@]([C@H](O)C)(Cn1cncn1)O


  • $277.00
  • Ex Tax: $277.00

Available Options